Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 11 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 8 9 10 11 presentations: 1 to 25 of 252
Primary analysis of the EORTC 10041/ BIG 3-04 MINDACT study: a prospective, randomized study evaluating the clinical utility of the 70-gene signature (MammaPrint) combined with common clinical-pathological criteria for selection of patients for adjuvant chemotherapy in breast cancer with 0 to 3 positive nodes
Martine Piccart
Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Discussant
Harold J Burstein
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Anti-proliferative response and predictive biomarkers to palbociclib in early breast cancer: The Preoperative Palbociclib (POP) randomized trial
Monica Arnedos
Institut Gustave Roussy, Villejuif, France
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Discussant
Nancy E. Davidson
University of Pittsburgh Cancer Institute, Pittsburgh, PA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Efficacy of T-DM1+pertuzumab over standard therapy for HER2+ breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL
Angela M DeMichele
University of Pennsylvania, Philadelphia, PA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Discussant
Mark D Pegram
UCLA School of Medicine, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
Low-fat dietary pattern and breast cancer mortality in the Women's Health Initiative (WHI) randomized trial
Rowan T Chlebowski
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:30 PM
The tumor immunity continuum as a framework for rational combinations
Priti S Hegde
Genentech, South San Francisco, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Combinations using checkpoint blockade as one means to address resistance
Jedd D. Wolchok
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
In vivo discovery of novel targets for cancer immunotherapy
Kai Wucherpfennig
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2016 on April 18, 2016 10:30 AM-12:15 PM
Invited speaker
Judy E. Garber
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
Helen M. Piwnica-Worms
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
Elizabeth M. Jaffee
Johns Hopkins University, Baltimore, MD, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
Channing J. Der
UNC Lineberger Comp. Cancer Center, Chapel Hill, NC, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
David Malkin
Univ. of Toronto Hospital for Sick Children, Toronto, ON, Canada
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
James P. Allison
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited Speaker
John M. Carethers
University of Michigan, Ann Arbor, MI, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited Speaker
John D. Carpten
USC Keck School of Medicine, Los Angeles, CA, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
Pratip Bhattacharya
MD Anderson Center, Houston, TX, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
William G. Kaelin
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Invited speaker
David J. Adams
Wellcome Trust Sanger Inst., Cambridge, United Kingdom
from AACR Annual Meeting 2016 on April 18, 2016 7:00 AM-8:00 AM
Isogenic tumors can utilize heterogeneous mechanisms of nutrient uptake
Craig B. Thompson
Memorial Sloan Kettering Cancer Center, New York, NY, United States
from AACR Annual Meeting 2016 on April 18, 2016 8:15 AM-10:15 AM
Transcriptional regulation by the MAX-like protein MLX is required for adaptive metabolic responses in development and tumorigenesis
Robert N. Eisenman
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
from AACR Annual Meeting 2016 on April 18, 2016 8:15 AM-10:15 AM
Targeted inhibition of IDHm in cancer
Katharine Yen
Agios Pharmaceuticals, Inc., Cambridge, MA, United States
from AACR Annual Meeting 2016 on April 18, 2016 8:15 AM-10:15 AM
Nutrient sensing pathways in cancer
David M. Sabatini
MIT Whitehead Institute for Biomed. Research, Cambridge, MA, United States
from AACR Annual Meeting 2016 on April 18, 2016 8:15 AM-10:15 AM
<< first | < prev page: of 11 records per page: next > | last >>
pages: 1 2 3 4 5 6 ... 8 9 10 11 presentations: 1 to 25 of 252